Prime Medicine
PRME
PRME
130 hedge funds and large institutions have $188M invested in Prime Medicine in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8.19% less ownership
Funds ownership: 57.24% → 49.05% (-8.2%)
29% less capital invested
Capital invested by funds: $266M → $188M (-$77.9M)
56% less call options, than puts
Call options by funds: $243K | Put options by funds: $553K
Holders
130
Holding in Top 10
1
Calls
$243K
Puts
$553K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$862K | |
| 3 | +$589K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$535K |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$498K |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$3.61M | |
| 3 | -$3.47M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.69M |
| 5 |
BlackRock
New York
|
-$2.17M |